Cover Image
市場調查報告書

居家醫療市場分析:各零件(設備(治療,診斷,移動支援)),各類服務(復建,(居家照護,呼吸系統治療服務,注射療法服務,遙測),及市場區隔預測

Home Healthcare Market Analysis By Component (Equipment (Therapeutic, Diagnostic, Mobility Assist)), Services (Rehabilitation, Unskilled Home Care, Respiratory Therapy Services, Infusion Therapy Services, Telemetry), And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 447121
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
居家醫療市場分析:各零件(設備(治療,診斷,移動支援)),各類服務(復建,(居家照護,呼吸系統治療服務,注射療法服務,遙測),及市場區隔預測 Home Healthcare Market Analysis By Component (Equipment (Therapeutic, Diagnostic, Mobility Assist)), Services (Rehabilitation, Unskilled Home Care, Respiratory Therapy Services, Infusion Therapy Services, Telemetry), And Segment Forecasts, 2014 - 2025
出版日期: 2017年01月04日 內容資訊: 英文 190 Pages
簡介

本報告提供全球居家醫療市場相關調查,彙整市場趨勢與今後的成長預測,各零件,各類服務,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 調查方法及調查範圍

第2章 摘要整理

第3章 市場變動,趨勢,範圍

  • 推動市場的要素分析
  • 滲透與成長預測製圖
  • SWOT分析
  • 產業分析:波特五力分析

第4章 各零件預測及趨勢分析

  • 各零件趨勢分析與市場佔有率
  • 各零件預測及趨勢分析
    • 設備
    • 服務

第5章 各地區預測及趨勢分析

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第6章 競爭環境

  • 策略架構
  • 企業簡介
目錄
Product Code: 978-1-68038-010-1

The global home healthcare market is expected to reach USD 517.2 billion by 2025, according to a new report by Grand View Research, Inc. Home healthcare products are generally applied to a broad range of equipment and services designed for exclusive use for home or other non-medical establishments by non-professional caregivers, family members, or the patients themselves.

Increasing adoption of telehealth and other emerging technologies are expected to drive market growth over the forecast period. Home healthcare is rapidly getting adopted as a cost effective alternative to healthcare establishment based therapy and therefore, growing geriatric population base and prevalence of chronic conditions requiring long term care is also expected to have a positive impact on growth. Presence of untapped potential in emerging markets such as India, Brazil and China and increasing health awareness are expected to serve home healthcare market as future growth opportunities.

Further key findings from the study suggest:

  • Home healthcare services dominated the component segment, accounting for over 85.0% of global revenue in 2015.
  • Infusion therapy is expected to be the fastest growing services market. Increasing initiatives undertaken by medical service providers to curb costs associated with specialty drugs and by retail pharmacies to render efficient chronic disease management solutions are some of the drivers of this market.
  • Home healthcare based diagnostics held lucrative share in the equipment segment accounting around 40.0% in 2015.
  • North America was the largest regional market in 2015, accounting for over 40.0% of the revenue. Presence of sophisticated medical systems and reimbursement infrastructure, high patient awareness levels and healthcare expenditure are some of the factors accounting for its substantial share.
  • Asia Pacific home healthcare market is expected to grow at the fastest CAGR of around 9.0% from 2016 to 2024 majorly owing to high unmet medical needs coupled with rapidly improving health infrastructure.
  • Major players in this vertical include Almost Family Inc., B. Braun Melsungen AG, Abbott Laboratories, Sunrise Medical Inc., 3M Health Care, Baxter, Medtronic, Cardinal Health Inc., Roche diagnostics corp., Air Liquide, Arcadia Health Care, Bayer AG, Amedisys, Inc., Nxstage Medical, Inc., and Arkray Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Scope & Assumptions
  • 1.3. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot

Chapter 3. Home Healthcare Market Variables, Trends & Scope

  • 3.1. Market Segmentation & Scope
  • 3.2. Market Driver Analysis
  • 3.3. Penetration & Growth Prospect Mapping
  • 3.4. SWOT Analysis, By Factor
    • 3.4.1. Political
    • 3.4.2. Economic
    • 3.4.3. Technological
  • 3.5. Industry Analysis - Porter's

Chapter 4. Home Healthcare Component Estimates & Trend Analysis

  • 4.1. Home Healthcare Movement Analysis & Market Share, 2015 & 2025
  • 4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 (USD Billion) for the Following Components:
    • 4.2.1. Equipment
      • 4.2.1.1. Therapeutic
      • 4.2.1.1.1. Home Respiratory Equipment
      • 4.2.1.1.2. Insulin Delivery Device
      • 4.2.1.1.3. Home IV Pumps
      • 4.2.1.1.4. Home Dialysis Equipment
      • 4.2.1.1.5. Other Therapeutic Equipment
      • 4.2.1.2. Diagnostics
      • 4.2.1.2.1. Diabetic Care Unit
      • 4.2.1.2.2. BP Monitors
      • 4.2.1.2.3. Multi Parameter Diagnostic Monitors
      • 4.2.1.2.4. Home Pregnancy and Fertility Kits
      • 4.2.1.2.5. Other Self-Monitoring Equipment
      • 4.2.1.2.6. Apnea and Sleep Monitors
      • 4.2.1.2.7. Holter Monitors
      • 4.2.1.2.8. Heart Rate Maters
      • 4.2.1.2.9. Other
      • 4.2.1.3. Mobility Assists
      • 4.2.1.3.1. Rehabilitation Services
      • 4.2.1.3.2. Unskilled Home Care
      • 4.2.1.3.3. Respiratory Therapy Services
      • 4.2.1.3.4. Infusion Therapy Services
      • 4.2.1.3.5. Telemetry
    • 4.2.2. Services
      • 4.2.2.1.1. Rehabilitation Services
      • 4.2.2.1.2. Unskilled Home Care
      • 4.2.2.1.3. Respiratory Therapy Services
      • 4.2.2.1.4. Infusion Therapy Services
      • 4.2.2.1.5. Telemetry

Chapter 5. Home Healthcare Regional Estimates & Trend Analysis

  • 5.1. Regional Movement Analysis & Market Share, 2015 & 2025
  • 5.2. North America
    • 5.2.1. U.S.
      • 5.2.1.1. U.S. revenue estimates and forecasts by, component (USD Billion) 2014 - 2025
    • 5.2.2. Canada
      • 5.2.2.1. Canada revenue estimates and forecasts by, component (USD Billion) 2014 - 2025
  • 5.3. Europe
    • 5.3.1. UK
      • 5.3.1.1. UK revenue estimates and forecasts by, component (USD Billion) 2014 - 2025
    • 5.3.2. Germany
      • 5.3.2.1. Germany revenue estimates and forecasts by, component (USD Billion) 2014 - 2025
  • 5.4. Asia Pacific
    • 5.4.1. Japan
      • 5.4.1.1. Japan revenue estimates and forecasts by, component (USD Billion) 2014 - 2025
    • 5.4.2. China
      • 5.4.2.1. China revenue estimates and forecasts by, component (USD Billion) 2014 - 2025
  • 5.5. Latin America
    • 5.5.1. Brazil
      • 5.5.1.1. Brazil revenue estimates and forecasts by, component (USD Billion) 2014 - 2025
    • 5.5.2. Mexico
      • 5.5.2.1. Mexico revenue estimates and forecasts by, component (USD Billion) 2014 - 2025
  • 5.6. MEA
    • 5.6.1. South Africa
      • 5.6.1.1. South Africa revenue estimates and forecasts by, component (USD Billion) 2014 - 2025

Chapter 6. Competitive Landscape

  • 6.1. Strategy Framework
  • 6.2. Company Profiles
    • 6.2.1. Almost Family Inc.
      • 6.2.1.1. Company Overview
      • 6.2.1.2. Financial Performance
      • 6.2.1.3. Product Benchmarking
      • 6.2.1.4. Strategic Initiatives
    • 6.2.2. B. Braun Melsungen AG
      • 6.2.2.1. Company Overview
      • 6.2.2.2. Financial Performance
      • 6.2.2.3. Product Benchmarking
      • 6.2.2.4. Strategic Initiatives
    • 6.2.3. Abbott Laboratories
      • 6.2.3.1. Company Overview
      • 6.2.3.2. Financial Performance
      • 6.2.3.3. Product Benchmarking
      • 6.2.3.4. Strategic Initiatives
    • 6.2.4. Sunrise Medical Inc.
      • 6.2.4.1. Company Overview
      • 6.2.4.2. Financial Performance
      • 6.2.4.3. Product Benchmarking
      • 6.2.4.4. Strategic Initiatives
    • 6.2.5. 3M Healthcare
      • 6.2.5.1. Company Overview
      • 6.2.5.2. Financial Performance
      • 6.2.5.3. Product Benchmarking
      • 6.2.5.4. Strategic Initiatives
    • 6.2.6. Baxter International Inc.
      • 6.2.6.1. Company Overview
      • 6.2.6.2. Financial Performance
      • 6.2.6.3. Product Benchmarking
      • 6.2.6.4. Strategic Initiatives
    • 6.2.7. Medtronic
      • 6.2.7.1. Company Overview
      • 6.2.7.2. Financial Performance
      • 6.2.7.3. Product Benchmarking
      • 6.2.7.4. Strategic Initiatives
    • 6.2.8. Cardinal Health Inc.
      • 6.2.8.1. Company Overview
      • 6.2.8.2. Financial Performance
      • 6.2.8.3. Product Benchmarking
      • 6.2.8.4. Strategic Initiatives
    • 6.2.9. Roche Diagnostics Corp.
      • 6.2.9.1. Company Overview
      • 6.2.9.2. Financial Performance
      • 6.2.9.3. Product Benchmarking
      • 6.2.9.4. Strategic Initiatives
    • 6.2.10. Roche Diagnostics Corp.
      • 6.2.10.1. Company Overview
      • 6.2.10.2. Financial Performance
      • 6.2.10.3. Product Benchmarking
      • 6.2.10.4. Strategic Initiatives
    • 6.2.11. Roche Diagnostics Corp.
      • 6.2.11.1. Company Overview
      • 6.2.11.2. Financial Performance
      • 6.2.11.3. Product Benchmarking
      • 6.2.11.4. Strategic Initiatives
    • 6.2.12. Air Liquide
      • 6.2.12.1. Company Overview
      • 6.2.12.2. Financial Performance
      • 6.2.12.3. Product Benchmarking
      • 6.2.12.4. Strategic Initiatives
    • 6.2.13. Arcadia Resources, Inc.
      • 6.2.13.1. Company Overview
      • 6.2.13.2. Financial Performance
      • 6.2.13.3. Product Benchmarking
      • 6.2.13.4. Strategic Initiatives
    • 6.2.14. Bayer Healthcare AG
      • 6.2.14.1. Company Overview
      • 6.2.14.2. Financial Performance
      • 6.2.14.3. Product Benchmarking
      • 6.2.14.4. Strategic Initiatives
    • 6.2.15. Amedisys, Inc.
      • 6.2.15.1. Company Overview
      • 6.2.15.2. Financial Performance
      • 6.2.15.3. Product Benchmarking
      • 6.2.15.4. Strategic Initiatives
    • 6.2.16. Nxstage Medical, Inc
      • 6.2.16.1. Company Overview
      • 6.2.16.2. Financial Performance
      • 6.2.16.3. Product Benchmarking
      • 6.2.16.4. Strategic Initiatives
    • 6.2.17. Arkray Inc.
      • 6.2.17.1. Company Overview
      • 6.2.17.2. Financial Performance
      • 6.2.17.3. Product Benchmarking
      • 6.2.17.4. Strategic Initiatives
    • 6.2.18. Apria Healthcare Group
      • 6.2.18.1. Company Overview
      • 6.2.18.2. Financial Performance
      • 6.2.18.3. Product Benchmarking
      • 6.2.18.4. Strategic Initiatives
    • 6.2.19. Odyssey Healthcare Inc.
      • 6.2.19.1. Company Overview
      • 6.2.19.2. Financial Performance
      • 6.2.19.3. Product Benchmarking
      • 6.2.19.4. Strategic Initiatives
    • 6.2.20. Becton, Dickinson and Company
      • 6.2.20.1. Company Overview
      • 6.2.20.2. Financial Performance
      • 6.2.20.3. Product Benchmarking
      • 6.2.20.4. Strategic Initiatives
    • 6.2.21. Critical Homecare
      • 6.2.21.1. Company Overview
      • 6.2.21.2. Financial Performance
      • 6.2.21.3. Product Benchmarking
      • 6.2.21.4. Strategic Initiatives
    • 6.2.22. National Healthcare Corp.
      • 6.2.22.1. Company Overview
      • 6.2.22.2. Financial Performance
      • 6.2.22.3. Product Benchmarking
      • 6.2.22.4. Strategic Initiatives
    • 6.2.23. Omron Healthcare, Inc.
      • 6.2.23.1. Company Overview
      • 6.2.23.2. Financial Performance
      • 6.2.23.3. Product Benchmarking
      • 6.2.23.4. Strategic Initiatives
    • 6.2.24. Drive Medical Design & Manufacturing
      • 6.2.24.1. Company Overview
      • 6.2.24.2. Financial Performance
      • 6.2.24.3. Product Benchmarking
      • 6.2.24.4. Strategic Initiatives
    • 6.2.25. Chubb Community Care
      • 6.2.25.1. Company Overview
      • 6.2.25.2. Financial Performance
      • 6.2.25.3. Product Benchmarking
      • 6.2.25.4. Strategic Initiatives
    • 6.2.26. Gambro AB
      • 6.2.26.1. Company Overview
      • 6.2.26.2. Financial Performance
      • 6.2.26.3. Product Benchmarking
      • 6.2.26.4. Strategic Initiatives
    • 6.2.27. GE Healthcare
      • 6.2.27.1. Company Overview
      • 6.2.27.2. Financial Performance
      • 6.2.27.3. Product Benchmarking
      • 6.2.27.4. Strategic Initiatives
    • 6.2.28. Medline Industries Inc.
      • 6.2.28.1. Company Overview
      • 6.2.28.2. Financial Performance
      • 6.2.28.3. Product Benchmarking
      • 6.2.28.4. Strategic Initiatives
    • 6.2.29. Philips Healthcare
      • 6.2.29.1. Company Overview
      • 6.2.29.2. Financial Performance
      • 6.2.29.3. Product Benchmarking
      • 6.2.29.4. Strategic Initiatives
    • 6.2.30. Medco Health Solutions Inc.
      • 6.2.30.1. Company Overview
      • 6.2.30.2. Financial Performance
      • 6.2.30.3. Product Benchmarking
      • 6.2.30.4. Strategic Initiatives
    • 6.2.31. Graham-Field Health Products Inc.
      • 6.2.31.1. Company Overview
      • 6.2.31.2. Financial Performance
      • 6.2.31.3. Product Benchmarking
      • 6.2.31.4. Strategic Initiatives
    • 6.2.32. Hill-Rom Holdings Inc.
      • 6.2.32.1. Company Overview
      • 6.2.32.2. Financial Performance
      • 6.2.32.3. Product Benchmarking
      • 6.2.32.4. Strategic Initiatives
    • 6.2.33. Gentiva Health Services Inc
      • 6.2.33.1. Company Overview
      • 6.2.33.2. Financial Performance
      • 6.2.33.3. Product Benchmarking
      • 6.2.33.4. Strategic Initiatives
    • 6.2.34. Johnson & Johnson
      • 6.2.34.1. Company Overview
      • 6.2.34.2. Financial Performance
      • 6.2.34.3. Product Benchmarking
      • 6.2.34.4. Strategic Initiatives
    • 6.2.35. Linde Healthcare
      • 6.2.35.1. Company Overview
      • 6.2.35.2. Financial Performance
      • 6.2.35.3. Product Benchmarking
      • 6.2.35.4. Strategic Initiatives
    • 6.2.36. Lincare Holdings, Inc.
      • 6.2.36.1. Company Overview
      • 6.2.36.2. Financial Performance
      • 6.2.36.3. Product Benchmarking
      • 6.2.36.4. Strategic Initiatives
    • 6.2.37. Kinetic Concepts
      • 6.2.37.1. Company Overview
      • 6.2.37.2. Financial Performance
      • 6.2.37.3. Product Benchmarking
      • 6.2.37.4. Strategic Initiatives
    • 6.2.38. Carefusion
      • 6.2.38.1. Company Overview
      • 6.2.38.2. Financial Performance
      • 6.2.38.3. Product Benchmarking
      • 6.2.38.4. Strategic Initiatives
    • 6.2.39. Vygon
      • 6.2.39.1. Company Overview
      • 6.2.39.2. Financial Performance
      • 6.2.39.3. Product Benchmarking
      • 6.2.39.4. Strategic Initiatives
    • 6.2.40. Teleflex
      • 6.2.40.1. Company Overview
      • 6.2.40.2. Financial Performance
      • 6.2.40.3. Product Benchmarking
      • 6.2.40.4. Strategic Initiatives
    • 6.2.41. Moog Inc.
      • 6.2.41.1. Company Overview
      • 6.2.41.2. Financial Performance
      • 6.2.41.3. Product Benchmarking
      • 6.2.41.4. Strategic Initiatives
    • 6.2.42. Intersurgical
      • 6.2.42.1. Company Overview
      • 6.2.42.2. Financial Performance
      • 6.2.42.3. Product Benchmarking
      • 6.2.42.4. Strategic Initiatives
    • 6.2.43. Fresenius Kabi
      • 6.2.43.1. Company Overview
      • 6.2.43.2. Financial Performance
      • 6.2.43.3. Product Benchmarking
      • 6.2.43.4. Strategic Initiatives

List of Tables

  • 1. North America home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 2. North America home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 3. North America home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 4. North America home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 5. North America home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 6. North America home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 7. U.S. home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 8. U.S. home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 9. U.S. home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 10. U.S. home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 11. U.S. home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 12. U.S. home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 13. Canada home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 14. Canada home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 15. Canada home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 16. Canada home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 17. Canada home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 18. Canada home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 19. Europe home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 20. Europe home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 21. Europe home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 22. Europe home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 23. Europe home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 24. Europe home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 25. UK home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 26. UK home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 27. UK home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 28. UK home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 29. UK home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 30. UK home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 31. Germany home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 32. Germany home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 33. Germany home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 34. Germany home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 35. Germany home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 36. Germany home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 37. Asia Pacific home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 38. Asia Pacific home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 39. Asia Pacific home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 40. Asia Pacific home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 41. Asia Pacific home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 42. Asia Pacific home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 43. Japan home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 44. Japan home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 45. Japan home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 46. Japan home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 47. Japan home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 48. Japan home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 49. China home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 50. China home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 51. China home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 52. China home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 53. China home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 54. China home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 55. Latin America home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 56. Latin America home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 57. Latin America home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 58. Latin America home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 59. Latin America home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 60. Latin America home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 61. Brazil home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 62. Brazil home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 63. Brazil home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 64. Brazil home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 65. Brazil home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 66. Brazil home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 67. Mexico home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 68. Mexico home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 69. Mexico home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 70. Mexico home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 71. Mexico home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 72. Mexico home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 73. MEA home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 74. MEA home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 75. MEA home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 76. MEA home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 77. MEA home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 78. MEA home healthcare market, by services, 2014 - 2025 (USD Billion)
  • 79. South Africa home healthcare market, by component, 2014 - 2025 (USD Billion)
  • 80. South Africa home healthcare equipment market, by product, 2014 - 2025 (USD Billion)
  • 81. South Africa home healthcare therapeutic product market, by type, 2014 - 2025 (USD Billion)
  • 82. South Africa home healthcare diagnostic product market, by type, 2014 - 2025 (USD Billion)
  • 83. South Africa home healthcare mobility assist product market, by type, 2014 - 2025 (USD Billion)
  • 84. South Africa home healthcare market, by services, 2014 - 2025 (USD Billion)

List of Figures

  • 1. Market summary
  • 2. Market trends & outlook
  • 3. Market segmentation & scope
  • 4. Market driver relevance analysis (Current & Future Impact)
  • 5. Market restraint relevance analysis (Current & Future Impact)
  • 6. Penetration & growth prospect mapping
  • 7. Home Healthcare PEST by SWOT analysis
  • 8. Porter's five forces analysis
  • 9. Home healthcare market component outlook key takeaways
  • 10. Home healthcare: Component movement analysis
  • 11. Home healthcare equipment market, 2014 - 2025 (USD Billion)
  • 12. Home healthcare therapeutic equipment market, 2014 - 2025 (USD Billion)
  • 13. Home respiratory equipment market, 2014 - 2025 (USD Billion)
  • 14. Infusion delivery equipment market, 2014 - 2025 (USD Billion)
  • 15. Home IV pumps market, 2014 - 2025 (USD Billion)
  • 16. Home dialysis equipment market, 2014 - 2025 (USD Billion)
  • 17. Other therapeutic equipment market, 2014 - 2025 (USD Billion)
  • 18. Home healthcare diagnostic equipment market, 2014 - 2025 (USD Billion)
  • 19. Diabetic care unit market, 2014 - 2025 (USD Billion)
  • 20. BP monitors market, 2014 - 2025 (USD Billion)
  • 21. Multi-parameter diagnostic monitors market, 2014 - 2025 (USD Billion)
  • 22. Home pregnancy kits market, 2014 - 2025 (USD Billion)
  • 23. Other self-monitoring equipment market, 2014 - 2025 (USD Billion)
  • 24. Apnea and sleep monitors market, 2014 - 2025 (USD Billion)
  • 25. Holter monitors market, 2014 - 2025 (USD Billion)
  • 26. Heart rate meters' market, 2014 - 2025 (USD Billion)
  • 27. Other home healthcare diagnostic equipment market, 2014 - 2025 (USD Billion)
  • 28. Home healthcare mobility assistive equipment market, 2014 - 2025 (USD Billion)
  • 29. Wheel chairs market, 2014 - 2025 (USD Billion)
  • 30. Home medical furniture market, 2014 - 2025 (USD Billion)
  • 31. Walking assist devices market, 2014 - 2025 (USD Billion)
  • 32. Home healthcare services market, 2014 - 2025 (USD Billion)
  • 33. Rehabilitation services market, 2014 - 2025 (USD Billion)
  • 34. Unskilled home care market, 2014 - 2025 (USD Billion)
  • 35. Respiratory therapy services market, 2014 - 2025 (USD Billion)
  • 36. Infusion therapy services market, 2014 - 2025 (USD Billion)
  • 37. Telemetry services market, 2014 - 2025 (USD Billion)
  • 38. Regional outlook, 2015 & 2025
  • 39. North America home healthcare market, 2014 - 2025 (USD Billion)
  • 40. U.S. home healthcare market, 2014 - 2025 (USD Billion)
  • 41. Canada home healthcare market, 2014 - 2025 (USD Billion)
  • 42. Europe home healthcare market, 2014 - 2025 (USD Billion)
  • 43. UK home healthcare market, 2014 - 2025 (USD Billion)
  • 44. Germany home healthcare market, 2014 - 2025 (USD Billion)
  • 45. Asia Pacific home healthcare market, 2014 - 2025 (USD Billion)
  • 46. UK home healthcare market, 2014 - 2025 (USD Billion)
  • 47. Germany home healthcare market, 2014 - 2025 (USD Billion)
  • 48. Asia Pacific home healthcare market, 2014 - 2025 (USD Billion)
  • 49. Japan home healthcare market, 2014 - 2025 (USD Billion)
  • 50. China home healthcare market, 2014 - 2025 (USD Billion)
  • 51. Latin America home healthcare market, 2014 - 2025 (USD Billion)
  • 52. Brazil home healthcare market, 2014 - 2025 (USD Billion)
  • 53. Mexico home healthcare market, 2014 - 2025 (USD Billion)
  • 54. MEA home healthcare market, 2014 - 2025 (USD Billion)
  • 55. Saudi Arabia home healthcare market, 2014 - 2025 (USD Billion)
Back to Top